Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ProPhase Labs, Inc. Director's Dealing 2017

Oct 5, 2017

34999_dirs_2017-10-05_1c7922fa-a740-4836-9ab8-6d2d7a5475a5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ProPhase Labs, Inc. (PRPH)
CIK: 0000868278
Period of Report: 2017-10-02

Reporting Person: Brady Monica L. (Chief Accounting Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, par value $0.0005 7400 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Option (right to buy) $2.15 2024-09-26 Common Stock (25000) Direct

Footnotes

F1: 25% of these shares were vested and exercisable as of September 26, 2017, the date of grant, and the remaining 75% of the shares will vest in three annual installments beginning on September 26, 2018.